- Easy Tracking In The Watchlist
Volatile ride for Acumen Pharmaceuticals, Inc. stock price on Friday moving between $2.12 and $2.35
(Updated on Jul 31, 2026)
The Acumen Pharmaceuticals, Inc. stock price fell by -0.92% on the last day (Friday, 31st Jul 2026) from $2.17 to $2.15. During the last trading day the stock fluctuated 10.61% from a day low at $2.12 to a day high of $2.35. The price has fallen in 6 of the last 10 days and is down by -4.44% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -74 thousand shares and in total, 259 thousand shares were bought and sold for approximately $557.86 thousand.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.04 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -5.46% during the next 3 months and, with a 90% probability hold a price between $1.93 and $2.56 at the end of this 3-month period.
ABOS Signals & Forecast
A buy signal was issued from a pivot bottom point on Wednesday, July 29, 2026, and so far it has risen 1.90%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Acumen Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.17 and $2.38. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Support, Risk & Stop-loss for Acumen Pharmaceuticals, Inc. stock
Acumen Pharmaceuticals, Inc. finds support from accumulated volume at $2.13 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.225 between high and low, or 10.61%. For the last week the stock has had daily average volatility of 8.12%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ABOS) For The Upcoming Trading Day Of Monday 3rd
For the upcoming trading day on Monday, 3rd we expect Acumen Pharmaceuticals, Inc. to open at $2.21, and during the day (based on 14 day Average True Range), to move between $2.07 and $2.23, which gives a possible trading interval of +/-$0.160 (+/-7.74%) up or down from last closing price. If Acumen Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 7.74% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $2.17 (0.93%) than the support at $2.13 (0.93%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Acumen Pharmaceuticals, Inc. stock A Buy?
Acumen Pharmaceuticals, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.
Current score:
-2.325
Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on August 3, 2026 - $2.21 ( 2.56%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
ABOS Performance
Trading levels for ABOS
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.43 | 13.02% |
| R2 | 2.34 | 9.03% |
| R1 | 2.29 | 6.56% |
| Price | 2.15 | |
| S1 | 2.12 | -1.44% |
| S2 | 2.07 | -3.91% |
| S3 | 1.98 | -7.91% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.36 | 9.77% |
| R2 | 2.25 | 4.65% |
| R1 | 2.17 | 0.93% |
| Price | 2.15 | |
| S1 | 2.13 | -0.93% |
| S2 | 2.11 | -1.86% |
| S3 | 0 | - |
FAQ
Click here for our free guide on how to buy Acumen Pharmaceuticals, Inc. Stock.
Buy ABOS